Entero Healthcare Solutions Ltd
Entero Healthcar | 544122
Stock Performance
Ratios
About Company
- Entero Healthcare Solutions Limited was incorporated as Entero Healthcare Solutions Private Limited' dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, at New Delhi
- Subsequently, the Company was converted into a public limited company and the name of the Company was changed to Entero Healthcare Solutions Limited', and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC
- The Company was founded in 2018 by Prabhat Agrawal, the Promoter to create an organized, pan-India, technology driven and integrated healthcare products distribution platform that can add value to the entire healthcare ecosystem
- The Company is the authorized distributor for most of the top pharmaceutical companies in India
- It also has strategic supply relationship with some of the leading corporate hospital chains of the country, The Company's primary line of business is in the distribution of healthcare products to retail pharmacies, hospitals and healthcare clinics in India
- The Company acquired 100% shareholding in Novacare Healthcare Solutions Private Limited, making it a wholly owned subsidiary in 2018
- In 2022, SS Pharma Traders Private Limited was acquired by the Company, making it a wholly owned subsidiary of the Company
- Enterprises Limited and Dhanvanthri Super Speciality Private Limited were acquired as 100% subsidiary of the Company
- The Company came up with an IPO of issuing 12,725,244 equity shares of Rs 10 each by raising capital aggregating to Rs 1600 Cr, comprising a fresh issue of 7,955,769 equity shares of Rs 1000 Cr and offer for sale of 4,769,475 equity shares to Rs 600 Cr in February, 2024
- Company expanded the product portfolio by managing over 80,600 SKUs sourced through 2700 healthcare product manufacturers in FY25 - a notable increase from 68,900+ in FY24
Ethics: Entero Healthcare Solutions Ltd is flagged for
Animal Cruelty
The company engages directly in some form of animal cruelty through its business.
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Top Gainers
Frequently Asked Questions
What is Share Price of Entero Healthcare Solutions Ltd?
The current share price of Entero Healthcare Solutions Ltd (Entero Healthcar) is ₹1028.30. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Entero Healthcare Solutions Ltd?
The Price-to-Earnings (P/E) ratio of Entero Healthcare Solutions Ltd is 1028.30. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Entero Healthcare Solutions Ltd?
Entero Healthcare Solutions Ltd has a 52-week high of ₹1510.80 and a 52-week low of ₹944.00. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Entero Healthcare Solutions Ltd?
Entero Healthcare Solutions Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Entero Healthcare Solutions Ltd?
The Earnings Per Share (EPS) of Entero Healthcare Solutions Ltd is ₹26.93. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Entero Healthcare Solutions Ltd?
Entero Healthcare Solutions Ltd has a Return on Equity (ROE) of 3.15%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
